SA Pathology: Ledger

Stories naming SA Pathology. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Investor	Rounds	Invested
No investors recorded yet. Know one?

Company	Kind	Announced	Price	Sources
SA Pathology is not recorded as having acquired anything.

Seed $10m

Australian collaboration and AU$10m investment fuels Ankere Therapeutics’ efforts to target inflammatory lung conditions

Biotech startup Ankere Therapeutics launches with a $10 million seed round co-led by IP Group and Brandon Capital to develop inflammatory lung disease therapies, building on research from Monash and UniSA scientists.

Also Brandon Capital portfolio·Startup Daily·@AuManufacturing

SA Pathology

Funding history

Investors

What SA Pathology bought

People

Coverage

Australian collaboration and AU$10m investment fuels Ankere Therapeutics’ efforts to target inflammatory lung conditions